It is also noted that in a pathological context, such as cancer, PA and Lp-PLA2 are differentially affected: PA is reduced in cases of high inflammatory burden, such as cancer and sarcopenia (49, 74), while Lp-PLA2 is increased (75). This evidence concerns the gene PLA2G7 and sarcopenia.